Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
about
Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissuesCathepsin G activity lowers plasma LDL and reduces atherosclerosisArterial indices and serum cystatin C level in individuals with occupational wide band noise exposure.Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient miceFibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury.Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells.Relative contributions of age and atherosclerosis to vascular stiffness.Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice.Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulationExpression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis.Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.Cathepsin K deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice.Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis.Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm.Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.Endothelial cells and cathepsins: Biochemical and biomechanical regulation.Influence of Selective Biochemical and Morphological Agents on Natural History of Aneurysm of Abdominal Aorta DevelopmentCysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.Degradation of the internal elastic laminae in vein grafts of rats with aortocaval fistulae: potential impact on graft vasculopathy.Autophagy dysfunction and regulatory cystatin C in macrophage death of atherosclerosis.Cystatin C: current position and future prospects.Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells.Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD.Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence.Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease.Developmental regulation of synthesis and dimerization of the amyloidogenic protease inhibitor cystatin C in the hematopoietic system.Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target.Molecular biology of atherosclerosis.Review of molecular and mechanical interactions in the aortic valve and aorta: implications for the shared pathogenesis of aortic valve disease and aortopathy.Cystatin C is a disease-associated protein subject to multiple regulation.Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular unitsSerum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.Role of cathepsin C in elastase-induced mouse abdominal aortic aneurysms.Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability.Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells
P2860
Q24594583-EC4BC9A3-31B0-4330-8750-F87A5E975044Q28245234-61B23082-4DA5-4664-B808-6827A3FEBAA9Q30364243-B4D97EE4-7791-4014-B34A-B3DB3E760E9EQ30528440-C851C9CA-5A89-4E0D-921B-CB170C398139Q33567746-583C3B2E-9E47-470A-976A-0F9EC9A180B6Q33605863-CA6BCEA6-0C9A-488C-9546-7E4F638257D4Q33712706-DCC13BB8-ECE3-44C8-9A8E-0F86FA6954F5Q33749964-5D9C8B95-377E-4EE5-9464-41B17B74F170Q33905277-045342ED-B5E1-42D2-8411-B020ABB588E6Q33947334-42ED9942-D9BD-4472-A4D8-F16CB4514BE5Q34062726-A25B4729-FE23-4C67-993D-29E943D08D79Q34581004-CA1EA528-A0AF-47E5-94D3-DCB4D268E083Q35098737-107C5F67-A23D-43AE-8EFC-906BD1CEBFA5Q35592574-99762734-2BE8-43A2-B1C7-114A430AA896Q35781497-64ED5995-3237-4F3C-8190-72D8A6B5D278Q35883165-3CF426E5-BB74-4E5B-A385-A445F806E590Q36211889-54A74B25-1B3F-4144-BA7A-17A4BFBF3951Q36262694-3A9C809E-2E70-4830-ADCA-1775747C4631Q36276616-68261D41-052E-4A98-9FAF-E2A1E58760F7Q36563605-E41E7AC2-2F66-43A3-92BC-11A83352D22CQ36572046-1690BF6C-1A6D-441C-ADF5-D68C1F2D185DQ36599238-3513AEA5-1E60-4449-9BD4-CF5186726E22Q37164242-2C79BAE2-DD4D-4FCA-BB33-160F3690B284Q37182981-C0A498C9-8A0B-4B2E-A65C-F9A90AD57CFCQ37313436-0FD444F5-5DF3-494D-B359-7FBAC4684878Q37471447-7FB91A4A-5BBB-48F0-868F-E4D67493223AQ37475650-5EC6702E-DC29-4F44-89BE-6109F26178B4Q37558931-D634E31E-ED64-42AD-A46E-D550358D9836Q37680650-30D8E4CC-91C9-4C56-A0F1-53339A049037Q37683390-80A36CCC-D954-499A-8057-D59200B41632Q37878492-963ED440-5B8B-4074-B93A-C25205E93AE4Q38125279-937549C3-A237-4FA0-A65A-F7E0287D1B60Q38269616-D380C6DA-E133-4A4D-AB8A-4D3D259D5407Q38341202-C350DDB4-82D6-4470-9FA4-FCD162B0FB1BQ38751291-AC64F967-84E3-4A27-A1F6-1CC4422E2CCFQ38769018-36052D5E-9E4C-4C17-BBCC-93508AFF35FDQ39261257-AAB05809-2CDD-4FBB-8551-A78296092BC7Q40159315-4D56C305-6715-42E7-8AA2-893C3EF61EEAQ41636688-4AF39321-11F0-4AC5-9E86-FB76C3D939BEQ41644080-40768EB7-9C8E-45D7-8F84-76EF319115E8
P2860
Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@en
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@nl
type
label
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@en
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@nl
prefLabel
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@en
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@nl
P2093
P1433
P1476
Cystatin C deficiency increase ...... in apolipoprotein E-null mice.
@en
P2093
Anders Grubb
Galina K Sukhova
Guo-Ping Shi
Harold A Chapman
Jie-Hong Pan
Kenneth Fang
Yaou Zhang
P304
P356
10.1161/01.RES.0000155964.34150.F7
P50
P577
2005-01-13T00:00:00Z